AlphAIAlphAI — Financial news for AI agents
seekingalpha.com

MariMed Non-GAAP EPS of -$0.01, revenue of $44.2M beats by $3M (OTCMKTS:MRMD)

MariMed reported Q3 Non-GAAP EPS of -$0.01 and revenue of $44.2M, exceeding estimates by $3M. Revenue grew 8.4% year-over-year. The company's cash position increased to $10.4M, the highest in two years. Shares rose 2.76%.

Original reporting
seekingalpha.com
Published Nov 11, 2026, 10:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 10:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
MariMed Non-GAAP EPS of -$0.01, revenue of $44.2M beats by $3M (OTCMKTS:MRMD) — source image
Source · seekingalpha.com
Decision brief

The 30-second read

Low
01

Why it matters

The earnings beat is modest and the company trades on the OTC market, limiting broader market impact.

02

Market read

Microcap earnings release with limited relevance to larger market participants.

03

What to watch

Liquidity constraints of an OTC microcap may limit price reaction.

Relevance 6/10Novelty 7/10Timing: post-market today

Background

MariMed (OTC: MRMD) released its Q3 earnings, reporting a slight revenue beat and a modest cash increase.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

No clear contrarian angle given the modest earnings beat.

Key entities

  • Company
    MariMed

    OTC-listed biotech reporting Q3 results.

Read at source← All news

Related articles

$MRMDMed

MariMed Reports Third Quarter 2026 Earnings

MARIMED INC. (MRMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MariMed Reports Third Quarter 2026 Earnings NORWOOD, MA, November 11, 2026 - MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for t

SEC EDGAR 8-K
$MRMDMed

MariMed Reports Second Quarter 2026 Earnings

MARIMED INC. (MRMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MariMed Reports Second Quarter 2026 Earnings NORWOOD, MA, August 12, 2026 - MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for th

SEC EDGAR 8-K
$EDRYMed

EuroDry Ltd. (EDRY): Financial results for 9M 2026

EuroDry Ltd. (EDRY) furnished an SEC Form 6-K — earnings release. INFORMATION CONTAINED IN THIS FORM 6-K REPORT Attached to this Report on Form 6-K as Exhibit 1 is a copy of the press release issued by EuroDry Ltd. (the “Company”) on November 11, 2026: EuroDry Ltd. Reports Results for the Quarter and Nine-Month Period Ended September 30, 2026.

SEC EDGAR 6-K
$IPWRMed

Ideal Power Reports Third Quarter 2026 Financial Results

Ideal Power Inc. (IPWR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ideal Power Reports Third Quarter 2026 Financial Results AUSTIN, TX – November 12, 2026 -- Ideal Power Inc. (Nasdaq: IPWR) (“Ideal Power,” the “Company,” “we,” “us” or “our”), developer and provider of its innovative and widely patented B-TRAN® bidirectional semicond

SEC EDGAR 8-K
$DGIIHighAI 8/10

Digi International Reports Fourth Fiscal Quarter and Full Year Fiscal 2026 Results

DIGI INTERNATIONAL INC (DGII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Digi International Reports Fourth Fiscal Quarter and Full Year Fiscal 2026 Results Record Quarterly Revenue of $143M, Record End of Quarter ARR of $197M Quarterly Cash Flow From Operations of $42M (Minneapolis, MN, November 11, 2026) - Digi International Inc. ("Digi"

SEC EDGAR 8-K